The Latest Cardiac and Vascular News
MADRID–(BUSINESS WIRE)–MedLumics, a medical device company developing fiber optically guided platform technologies for the treatment, initially, of Atrial fibrillation (AF), announced today 10 patients treated in the company’s First in Man clinical trial. The AblaView Unipolar Pulsed Field (PF) Ablation System, used in this trial, features MedLumics unique, real-time, fiber […]
– MedLumics’ oversubscribed financing round closes at EUR 18M to advance optically-guided real-time ablation catheter technology for the treatment of Atrial Fibrillation – MedTech veteran, Rich Ferrari, joins MedLumics’ Board of Directors as new Chairman MADRID, Feb. 10, 2021 /PRNewswire/ — MedLumics, a privately held medical device company developing AblaView®, the first […]
– MedLumics is developing a unique real-time, optically-guided ablation catheter to improve treatment of Atrial Fibrillation by RadioFrequency Ablation and Pulsed Field Ablation – Presentation on Direct Lesion Assessment using Photonics during AF Ablation MADRID, Jan. 28, 2021 /PRNewswire/ — MedLumics, a privately held medical technology company developing AblaView®, an optically-guided RadioFrequency […]
